Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Lacey

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2010
A ligand for CD5 is CD5Marion H Brown, Erica Lacey
Journal of Autoimmunity|June 1, 2012
Immune complex-mediated co-ligation of the BCR with FcγRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosusVerica Paunovic, Natalie A Carter, Theresa Thalhamer, et al.
Human Molecular Genetics|November 16, 2013
The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy miceCharlotte Whitmore, Marta Fernandez-Fuente, Helen Booler, et al.
Neuromuscular Disorders : NMD|November 13, 2014
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patientsEmma L Humphrey, Erica Lacey, Lam T Le, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|October 19, 2010
A ligand for CD5 is CD5Marion H Brown, Erica Lacey
Journal of Autoimmunity|June 1, 2012
Immune complex-mediated co-ligation of the BCR with FcγRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosusVerica Paunovic, Natalie A Carter, Theresa Thalhamer, et al.
Human Molecular Genetics|November 16, 2013
The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy miceCharlotte Whitmore, Marta Fernandez-Fuente, Helen Booler, et al.
Neuromuscular Disorders : NMD|November 13, 2014
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patientsEmma L Humphrey, Erica Lacey, Lam T Le, et al.
Pageof 1